Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-262640
Filing Date
2020-10-02
Accepted
2020-10-02 17:18:29
Documents
3
Effectiveness Date
2020-10-02

Document Format Files

Seq Description Document Type Size
1 S-8 d60538ds8.htm S-8 74167
2 EX-5.1 d60538dex51.htm EX-5.1 4465
3 EX-23.1 d60538dex231.htm EX-23.1 1416
  Complete submission text file 0001193125-20-262640.txt   81072
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-249286 | Film No.: 201221223
SIC: 2836 Biological Products, (No Diagnostic Substances)